A Phase III, Multicenter, Randomized, Parallel Group, Double Blind, Double Dummy, Active Controlled Study of Evobrutinib Compared with Teriflunomide, in Participants with Relapsing Multiple Sclerosis to Evaluate Efficacy and Safety.

Public Engagement
Phase III Clinical Trial in RRMS patients.

Overview

Term type

03 - Tematica relativa alle scienze della vita e salute

Linked Units

DIPARTIMENTO DI NEUROSCIENZE, IMAGING E SCIENZE CLINICHE (Coordinatore/trice o Organizzatore/trice)

Research

Concepts


Goal 3: Good health and well-being

Free text keywords (3)

BTK INHIBITOR
EVOBRUTINIB
MULTIPLE SCLEROSIS
No Results Found

Affiliations

Responsibles

TOMASSINI VALENTINA (Organizzatore/Organizzatrice, Partecipante)

Members

TOMASSINI VALENTINA (Organizzatore/Organizzatrice, Partecipante)